Brown & Brown (BRO) is experiencing significant activity in the biotech market. Underpins include
Headwaters Capital Management and
Landscape Capital Management L.L.C. acquiring stakes. The firm's yearly returns are adjusting to align with its earnings growth after a weekly decline of 9.4%. Notably,
Barclays and
Morgan Stanley revised their price targets ahead of Q1 2025 Earnings Call, scheduled for April 28. Large quantities of BRO shares have been sold by several investors, like Russell Investments Group Ltd., but simultaneously, the stock has seen new acquisitions by firms like
Advisory Services Network LLC,
Franklin Resources Inc., and
Arrowstreet Capital Limited Partnership. Jeffries has also adjusted its price target for BRO amidst uncertain market conditions. Its performance in the past week has been notably up by 0.27%. Moreover, Jim Cramer dubbed it an “
Insurance Stock That’s Red Hot!”. However, despite some temporary setbacks like its recent downgrade, analysts still consider BRO as a strong long-term growth prospect.
Brown Brown BRO News Analytics from Wed, 27 Mar 2024 07:09:54 GMT to Sat, 12 Apr 2025 23:14:21 GMT -
Rating 6
- Innovation 2
- Information 8
- Rumor -3
